Aligos Therapeutics Inc (ALGS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aligos Therapeutics Inc   (NASDAQ: ALGS)


Aligos Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aligos Therapeutics Inc's ROI in the second quarter of 2026?
Aligos Therapeutics Inc recorded a cumulative net loss of $-76 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -123.88%.

Within the Healthcare sector 639 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3745 to 4079.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -33.54 % -3.28 % 34.02 % 0.91 % -4.21 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 38 45 71 91 118
Return On Investment (TTM) -123.88 % -111.07 % -23.29 % -88.02 % -80.41 %
ALGS's Overall Ranking # 4079 # 3745 # 2364 # 3735 # 3500
Seq. Investment Change TTM -24.59 % -21.73 % 5.77 % 6.47 % 9.73 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -76 -90 -24 -86 -74

ALGS Company Profile >> Back to ALGS Roi Comparisons >> See Annual ALGS Return On Investment



Return On Investment ALGS's Ranking
Within: No.
Industry # 109
Sector # 640
Overall # 4079

Return On Investment Statistics
High Average Low
-23.29 %
-80.56 %
-169.25 %
(Dec 31 2025)   (Dec 31 2024)







Financial Statements
Aligos Therapeutics Inc's II. Quarter Investments $ 38 Millions ALGS's Balance sheet
Aligos Therapeutics Inc's II. Quarter Income $ -2 Millions Quarterly ALGS's Income Statement
ALGS's Income by Division See ALGS's Income by Division


ALGS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 67 48 128 114 196
Y / Y Investment Growth 39.17 % -62.11 % 12.38 % -42.18 % -16.43 %
Net Income in Millions -24 -131 -88 -96 -128
Y / Y Net Income Growth - - - - -
Annual Return On Investment -35.95 % -271.34 % -68.7 % -84.57 % -65.34 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ALGS's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ALGS's Competitors
Subscribers only: Roi for Aligos Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ALGS's Customers

Other Ratios
ALGS's Roa ALGS's Inventory Turnover Ratio ALGS's Growth Rates ALGS's Dividend Statistics
ALGS's Profitability Ratios ALGS's Asset Turnover Ratio ALGS's Dividend Growth
ALGS's Roe ALGS's Valuation Ratios ALGS's Financial Strength Ratios ALGS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T10:47:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.